Meridian Medica — Turmeric

01

Identity

Botanical Profile

Curcuma longa L. — Rhizome. South Asia (India, Southeast Asia); cultivated worldwide in tropical regions

Rhizome: warm, bitter, earthy, slightly peppery. Fresh: bright orange-yellow, musky aroma. Dried powder: deep golden-orange, characteristic warm fragrance. Stains skin and surfaces intensely.

Species Integrity

Turmeric faces significant adulteration risks globally. Lead chromate has been documented as a coloring adulterant in Bangladeshi turmeric (Forsyth et al., Stanford, 2019). Other concerns include addition of synthetic dyes (metanil yellow, Sudan dyes) to enhance color, starch dilution, and species substitution with Curcuma zedoaria or Curcuma aromatica.

02

Compounds

Active Compound Profile

Curcumin (diferuloylmethane)

2–5% dry wt (up to 8% in standardized extracts)

NF-κB inhibition; COX-2 suppression; Nrf2 activation; direct TPO antibody modulation (Bourbour 2026)

Demethoxycurcumin

1–2% dry wt

Similar NF-κB and COX-2 inhibition; may have superior anti-cancer activity

Bisdemethoxycurcumin

0.5–1% dry wt

Strongest Nrf2 activator of the three curcuminoids; antioxidant defense upregulation

Turmerones (ar-turmerone)

25–45% of volatile oil fraction

Anti-inflammatory; neuroprotective; enhances curcumin absorption independently of piperine

Turmeric polysaccharides

Variable

Immunomodulatory; prebiotic potential

curcumin

Absorption

Piperine co-administration: Piperine inhibits hepatic and intestinal glucuronidation of curcumin, increasing bioavailability by 2,000% (Shoba et al., 1998, PMID: 9619120)

03

Pathways

Mechanism of Action

★★★☆☆ NF-κB / Inflammatory Cytokine Axis Curcumin directly inhibits IκB kinase (IKK) and blocks NF-κB nuclear translocation; suppresses TNF-α, IL-1β, IL-6, IL-8 production at the transcriptional level

★★★☆☆ COX-2 / Prostaglandin Axis Curcumin inhibits COX-2 expression and activity; reduces PGE2 synthesis

★★★☆☆ Nrf2 / Antioxidant Defense Bisdemethoxycurcumin and curcumin activate Nrf2, upregulating glutathione (GSH), superoxide dismutase (SOD), heme oxygenase-1 (HO-1), and catalase

★★★☆☆ Th1/Th2/Th17 Immune Modulation Curcumin suppresses Th17 differentiation and IL-17 production; modulates Th1/Th2 balance toward reduced autoimmune attack

★★★☆☆ Phase II Liver Detoxification Curcumin upregulates glutathione S-transferase (GST) and UDP-glucuronosyltransferase via Nrf2; enhances bile flow (cholagogue)

★★★☆☆ AMPK / Insulin-Leptin Axis Curcumin activates AMPK; improves insulin receptor sensitivity; modulates leptin signaling

04

Biomarkers

Documented Biomarker Effects

Biomarker	Direction	Target	Mechanism
TPO Antibodies	↓ Decrease	<35 IU/mL	Direct: curcumin reduces TPO antibodies via NF-κB inhibition and Th17 suppression (Bourbour 2026, p=0.006)
hs-CRP	↓ Decrease	<1.0 mg/L	NF-κB inhibition and COX-2 suppression reduce systemic inflammatory markers
Fasting Glucose	↓ Decrease	<100 mg/dL	AMPK activation improves hepatic and peripheral insulin sensitivity
HbA1c	↓ Decrease	<5.7%	Sustained glucose regulation via AMPK and insulin receptor sensitization
ALT/AST	↓ Decrease (if elevated)	Normal range	Hepatoprotective effects via Nrf2 antioxidant defense and reduced hepatic inflammation

05

Extraction

Extraction & Preparation

Raw grated (fresh rhizome): 95%+ curcuminoids; full turmerones

Solubility · Poorly water-soluble; soluble in ethanol, DMSO, and oils. Heat increases water solubility 12-fold.Menstruum · 70% ethanolPlant material · Fresh rhizome, finely sliced or grated; or dried root powderMaceration time · 4–6 weeksRatio · 1:2 (fresh) or 1:5 (dried)

06

Biomarker Intel

Biomarker Intelligence

This herb has documented effects on the following markers:

Marker	Direction	Evidence	Notes
TPO Antibodies	↓ Decrease	traditional	Direct: curcumin reduces TPO antibodies via NF-κB inhibition and Th17 suppression (Bourbour 2026, p=0.006)
hs-CRP	↓ Decrease	traditional	NF-κB inhibition and COX-2 suppression reduce systemic inflammatory markers
Fasting Glucose	↓ Decrease	traditional	AMPK activation improves hepatic and peripheral insulin sensitivity
HbA1c	↓ Decrease	traditional	Sustained glucose regulation via AMPK and insulin receptor sensitization
ALT/AST	↓ Decrease (if elevated)	traditional	Hepatoprotective effects via Nrf2 antioxidant defense and reduced hepatic inflammation

07

Dosing

Dosing Framework

Take turmeric with meals containing fat for optimal absorption (curcuminoids are lipophilic).

Dose 1

Culinary: 1–3 tsp whole powder/day

MUST include fat + black pepper; achievable as daily cooking spice

Dose 2

Moderate: 500mg curcumin extract

Standardized 95% curcuminoids with piperine; 1–2 caps/day

Dose 3

Therapeutic: 1000–1500mg curcumin extract

Bourbour 2026 used 1320mg/day; divide into 2 doses with fatty meals

08

Synergies

Synergy Partners

★★★☆☆ Black Pepper (Piper nigrum) Piperine inhibits glucuronidation of curcumin, increasing bioavailability 2,000% (Shoba et al., 1998). This is the most well-documented herb-herb synergy in pharmacology.

★★★☆☆ Ginger (Zingiber officinale) Complementary COX-2/5-LOX inhibition via different binding sites; ginger's gastroprokinetic effect enhances curcumin transit and absorption

★★★☆☆ Boswellia (Boswellia serrata) Boswellic acids inhibit 5-LOX while curcumin inhibits COX-2; non-overlapping pathway coverage; synergistic 1+1=3 anti-inflammatory effect

★★★☆☆ Ghee / Coconut Oil Saturated fats form stable micelles for curcuminoid transport across intestinal epithelium; 7–8 fold absorption increase

★★★☆☆ Omega-3 fatty acids Complementary anti-inflammatory pathways: omega-3 resolvin production + curcumin NF-κB inhibition; shared lipid transport enhances co-absorption

Signature Stack

THE GOLDEN TRIO
Components: Turmeric (rhizome) + Ginger (rhizome) + Black Pepper (fruit) · Multi-pathway convergence: NF-κB suppression (turmeric) + COX-2/5-LOX inhibition (ginger) + bioavailability multiplication (piperine) + Nrf2 activation (all three) · Turmeric is the centerpiece — it now has direct Hashimoto's TPO reduction data (Bourbour 2026). · This combination addresses inflammation from three angles simultaneously, with piperine ensuring the curcuminoids actually reach systemic circulation. Include in daily cooking, golden milk, or supplemental form.

09

Safety

Contraindications & Interactions

Minor Anticoagulant interaction Curcumin inhibits platelet aggregation and may potentiate warfarin, aspirin, and other anticoagulants at supplemental doses (>500mg curcumin). Culinary doses generally safe.

Minor Gallbladder disease Turmeric is a potent cholagogue (stimulates bile flow and gallbladder contraction). Contraindicated in bile duct obstruction; may cause discomfort with active gallstones.

Avoid Pregnancy / lactation Culinary doses considered safe (AHPA Class 1 at food levels). High-dose curcumin extracts lack adequate pregnancy safety data. HomeGrown Herbalist notes safe during pregnancy and nursing at food/tincture doses.

Minor Iron absorption Curcumin may chelate iron at high doses, potentially reducing absorption of non-heme iron supplements.

Minor Oxalate content Turmeric contains oxalates (1.6–2.9% dry weight); high consumption may increase urinary oxalate in susceptible individuals.

Minor Lead contamination risk Documented lead chromate adulteration in South Asian turmeric supply chain (Forsyth et al., 2019). Synthetic dye adulteration also reported.

11

Evidence

Evidence Base

★★★★★ Anti-Inflammatory (General) Definitive — Multiple RCTs + meta-analyses; mechanism fully characterized

★★★★☆ Hashimoto's / TPO Antibody Reduction Strong — Direct Hashimoto's RCT now available

★★★★★ Bioavailability Enhancement (Piperine) Definitive — Landmark human study; mechanism fully characterized

★★★★☆ Osteoarthritis Pain Strong — Multiple RCTs; non-inferiority to NSAIDs demonstrated

★★★☆☆ Depression / Mood Moderate — Multiple RCTs with positive direction; mechanism plausible

★★★★★ Lead Chromate Adulteration Definitive — Documented public health concern

Evidence Gaps

The remaining highest-value research gap: no published RCT has evaluated whole turmeric powder as a daily culinary intervention (vs. standardized curcumin extract) in women with Hashimoto's using biomarker endpoints (TPO, TgAb, hs-CRP, fasting glucose).

Quality Alert

12

Protocol

Preparation Integration

Recipe Integration

Golden Milk (signature preparation)

1 tsp turmeric powder (~80mg curcuminoids)